Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab.
about
Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease.Smoking and rheumatoid arthritis.Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritisSerum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis.
P2860
Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Low circulating soluble interl ...... ritis treated with infliximab.
@ast
Low circulating soluble interl ...... ritis treated with infliximab.
@en
type
label
Low circulating soluble interl ...... ritis treated with infliximab.
@ast
Low circulating soluble interl ...... ritis treated with infliximab.
@en
prefLabel
Low circulating soluble interl ...... ritis treated with infliximab.
@ast
Low circulating soluble interl ...... ritis treated with infliximab.
@en
P2093
P2860
P356
P1476
Low circulating soluble interl ...... hritis treated with infliximab
@en
P2093
Kautiainen H
Leirisalo-Repo M
Nissinen R
P2860
P356
10.1136/ARD.2004.034728
P407
P577
2005-06-07T00:00:00Z